GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Common Stock

Pharmaresearch Bio Co (XKRX:217950) Common Stock : ₩2,032 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Common Stock?

Pharmaresearch Bio Co's quarterly common stock stayed the same from Dec. 2021 (₩2,025 Mil) to Dec. 2022 (₩2,025 Mil) but then increased from Dec. 2022 (₩2,025 Mil) to Dec. 2023 (₩2,032 Mil).

Pharmaresearch Bio Co's annual common stock stayed the same from Dec. 2021 (₩2,025 Mil) to Dec. 2022 (₩2,025 Mil) but then increased from Dec. 2022 (₩2,025 Mil) to Dec. 2023 (₩2,032 Mil).


Pharmaresearch Bio Co Common Stock Historical Data

The historical data trend for Pharmaresearch Bio Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Common Stock Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 2,024.70 2,024.70 2,024.70 2,024.70 2,032.20

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock Get a 7-Day Free Trial 2,024.70 2,024.70 2,024.70 2,024.70 2,032.20

Pharmaresearch Bio Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Pharmaresearch Bio Co Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines